e-learning
resources
Vienna 2009
Monday, 14.09.2009
Inflammatory cells and cytokines
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bacterial endotoxin-induced T-lymphocyte immune response is impaired in COPD – effect of moxifloxacin and dexamethasone
K. Schild, D. Jungck, L. Njue, J. Quernheim, S. Chikosi, K. Urban, J. Knobloch, A. Koch (Cologne, Germany)
Source:
Annual Congress 2009 - Inflammatory cells and cytokines
Session:
Inflammatory cells and cytokines
Session type:
Thematic Poster Session
Number:
2135
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Schild, D. Jungck, L. Njue, J. Quernheim, S. Chikosi, K. Urban, J. Knobloch, A. Koch (Cologne, Germany). Bacterial endotoxin-induced T-lymphocyte immune response is impaired in COPD – effect of moxifloxacin and dexamethasone. Eur Respir J 2009; 34: Suppl. 53, 2135
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Low dose inhaled LPS challenge – Reproducibility of the inflammatory response
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Effects of
Bu-Zhong-Yi-Qi-Tang
(
Hochuekkito;
TJ-41) on the inflammatory responses in alveolar macrophages of hyperglycemic mice
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011
In COPD moxifloxacin enhances th1-immune response in the presence of bacterial endotoxin by inducing IL-2 expression
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
Evidence for cell mediated immune dysfunction in the COPD lung: The role of cytotoxic CD4+ T cells
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Lung-epithelial C/EBPβ plays a role in the effects of budesonide and formoterol on the inflammatory response to LPS
in vivo
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
β
2
long-acting and anticholinergic drugs synergistically control TGFβ1-mediated neutrophilic inflammation in COPD: An
"in vitro"
model
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Macrolide effects on the prevention of COPD exacerbations
Source: Eur Respir J 2012; 40: 485-494
Year: 2012
Reverbα is a novel regulator of COPD macrophage inflammation and glucocorticoid resistance
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
LSC - 2019 - Anti-IL5 in mild asthma alters rhinovirus-induced macrophage, B cell and neutrophil responses
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Nontypeable
haemophilus influenzae leads to activation of the NLRP3 inflammasome – A possible trigger of chronic bronchial inflammation in COPD
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Use of lipids in a murine model of ALI and lymphocyte apoptosis – Harmful or beneficial?
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Differential effects of simvastatin and dexamethasone on TLR3-induced anti-viral cytokines in asthmatic epithelium
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Reduced plasma vitamin D concentration is associated with humoral immunity in pigeon fanciers‘ hypersensitivity pneumonitis [HP]
Source: Annual Congress 2010 - Organic dust, allergen exposure and respiratory disease
Year: 2010
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002
Levofloxacin prevents eosinophil activation and asthma exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 207s
Year: 2006
Impairment of endothelial function by chronic intermittent hypoxia in ApoE-/- mice – Implications for anti-inflammatory and anti-oxidative treatment
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012
Aerobic training reverses the inhibition in the expression of glucocorticoid receptors and decreases the Th2 allergic inflammation in asthma model
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept